Clinical Trials Logo
NCT number NCT01642134
Study type Interventional
Source Hospital de Meixoeiro
Contact Pablo Juan Salvadores, Pharma, MPH
Phone 0034986825564
Email pablo.juan.salvadores@sergas.es
Status Recruiting
Phase Phase 4
Start date April 2013
Completion date June 2018

Clinical Trial Summary

The purpose of this study is to determine the incidence of major vascular events (ischemic or haemorrhagics) at the third month after initiation of the antithrombotic treatment (oral anticoagulation or dual antiplatelet therapy) in both arms followed TAVI.


Clinical Trial Description

Transcatheter aortic valve implantation (TAVI) procedure using any of their vascular access is an option with proven benefit definitively for treatment of severe symptomatic aortic stenosis in patients considered unsuitable for conventional open heart surgery.

By avoiding the hemodynamic effects, cardiovascular and cerebral microembolic load of cardiopulmonary bypass circulation, it is assumed that the TAVI procedure is beneficial despite the risk of neurological complications. Currently antithrombotic therapy after the procedure is not standardized. International treatment guidelines recommends that post-operative patients with a conventional surgical aortic bioprosthesis maintain oral anticoagulation for 3 months after the procedure, unless otherwise noted for its continuation. Whereas some studies have postulated that in patients with aortic bioprostheses, dual antiplatelet therapy is as effective to prevent major cardiac and cerebrovascular events as oral anticoagulation, with a lower incidence of bleeding complications at 3 months of treatment, the investigators formulated the following hypothesis:

• There is a lower incidence of major cardiac and cerebrovascular events in patients with dual antiplatelet therapy compared to patients with oral anticoagulation for 3 months after implantation of an aortic bioprosthesis TAVI procedure.


Study Design


Related Conditions & MeSH terms


See also
Status Clinical Trial Phase
 Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
 Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
 Recruiting NCT02822144 - General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke Phase 3
 Not yet recruiting NCT03177954 - Developing a Patient Oriented Discharge Summary for Stroke Inpatients N/A
 Recruiting NCT02917213 - Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction N/A
 Recruiting NCT02889562 - Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation Phase 2/Phase 3
 Recruiting NCT02916030 - Vitamin D and Stroke N/A
 Recruiting NCT02960009 - Motor Excitability Study of High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Chronic Stroke N/A
 Recruiting NCT02828306 - Computer Based Algorithm for Patient Specific Implants for Cranioplasty in Patients With Skull Defects N/A
 Recruiting NCT03080454 - The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke N/A
 Recruiting NCT02906956 - Music and Adherence Home Programs Post Stroke Phase 0
 Recruiting NCT03183635 - Rapid Movement Therapy for Stroke Rehabilitation N/A
 Active, not recruiting NCT02753257 - Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation N/A
 Enrolling by invitation NCT02898558 - Effect of Body Representation in Movement N/A
 Completed NCT02868996 - An Open Label, Phase 1b, Ascending Dose Study of DM199 Phase 1
 Completed NCT03053154 - Relationship Between Pelvic Tilt and Sit to Stand Task in Stroke Patients N/A
 Completed NCT03025776 - One vs. Two Hand Use After Stroke: Role of Task Requirements Phase 0
 Recruiting NCT02625948 - Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign Phase 2
 Recruiting NCT02550015 - High Intensity Interval Training After Stroke N/A
 Recruiting NCT02533128 - Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery N/A